nedaplatin has been researched along with Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (9.09) | 18.7374 |
| 1990's | 3 (27.27) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 2 (18.18) | 2.80 |
| Authors | Studies |
|---|---|
| Harasawa, H; Hashizume, J; Kodama, Y; Nakagawa, H; Nambu, M | 1 |
| Kong, Y; Li, X; Liu, W; Liu, X; Mu, X; Pang, J | 1 |
| Hou, A; Jiang, Z; Liu, W; Mu, Y; Tan, S; Yu, C | 1 |
| Fong, CW | 1 |
| Ando, Y; Araki, R; Iwamizu, H; Kataoka, T; Kumakura, Y; Miyazaki, M; Nagai, T; Yamada, K | 1 |
| Huang, XE; Jiang, Y; Li, Y; Xiang, J; Yan, PW | 1 |
| Ishibashi, T; Oguma, T; Yano, Y | 1 |
| Christian, MC | 1 |
| Ariyoshi, Y; Inuyama, Y; Kimura, I; Majima, H; Niitani, H; Ogawa, M; Ota, K; Taguchi, T; Wakui, A; Yoshida, O | 1 |
| Amano, T; Eguchi, K; Kojima, A; Morita, M; Ohe, Y; Saijo, N; Sasaki, Y; Shinkai, T; Tamura, T | 1 |
| Ariyoshi, Y; Ota, K | 1 |
1 review(s) available for nedaplatin and Neoplasms
| Article | Year |
|---|---|
The current status of new platinum analogs.
Topics: Animals; Antineoplastic Agents; Carboplatin; Chemistry, Pharmaceutical; Cyclobutanes; Drugs, Investigational; Forecasting; Humans; Neoplasms; Organoplatinum Compounds; Oxaliplatin | 1992 |
3 trial(s) available for nedaplatin and Neoplasms
| Article | Year |
|---|---|
Shen-Cao granules formulated based on traditional Chinese medicine alleviates bone marrow suppression caused by platinum-based anticancer reagents.
Topics: Adult; Aged; Antineoplastic Agents; Blood Platelets; Bone Marrow; Bone Marrow Diseases; Carboplatin; Cisplatin; Drug Therapy, Combination; Female; Humans; Male; Medicine, Chinese Traditional; Middle Aged; Neoplasms; Organoplatinum Compounds; Platelet Activation; Platelet Aggregation; Platinum Compounds; Thrombocytopenia; Young Adult | 2017 |
Efficacy and safety of endostar combined with chemotherapy in patients with advanced solid tumors.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Carboplatin; Cisplatin; Deoxycytidine; Docetaxel; Endostatins; Female; Fluorouracil; Gemcitabine; Humans; Irinotecan; Leucovorin; Male; Middle Aged; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Recombinant Proteins; Survival Rate; Taxoids; Treatment Outcome | 2010 |
Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion.
Topics: Adult; Aged; Antineoplastic Agents; Drug Evaluation; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Organoplatinum Compounds | 1991 |
7 other study(ies) available for nedaplatin and Neoplasms
| Article | Year |
|---|---|
Poor Renal Function and a High Modified Glasgow Prognostic Score Are Predictive Factors for Nedaplatin/5-Fluorouracil Combination Therapy-induced Febrile Neutropenia.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Febrile Neutropenia; Fluorouracil; Granulocyte Colony-Stimulating Factor; Mice; Neoplasms; Prognosis; Retrospective Studies | 2023 |
Galactosylated Chitosan Modified Magnetic Mesoporous Silica Nanoparticles Loaded with Nedaplatin for the Targeted Chemo-Photothermal Synergistic Therapy of Cancer.
Topics: Cell Line, Tumor; Chitosan; Doxorubicin; Drug Delivery Systems; Drug Liberation; Magnetic Phenomena; Nanoparticles; Neoplasms; Organoplatinum Compounds; Phototherapy; Porosity; Silicon Dioxide | 2021 |
Platinum based radiochemotherapies: Free radical mechanisms and radiotherapy sensitizers.
Topics: Antineoplastic Agents; Carboplatin; Chemoradiotherapy; Cisplatin; DNA Adducts; DNA Damage; Drug Synergism; Electrons; Fluorouracil; Free Radicals; Humans; Neoplasms; Organoplatinum Compounds; Oxaliplatin; Oxidation-Reduction; Radiation-Sensitizing Agents | 2016 |
[Analysis of Nedaplatin Dose in Patients with Impaired Renal Function].
Topics: Adult; Aged; Antineoplastic Agents; Female; Humans; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Neoplasms; Organoplatinum Compounds; Retrospective Studies; Risk Factors | 2017 |
A formula for predicting optimal dosage of nedaplatin based on renal function in adult cancer patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Area Under Curve; Dose-Response Relationship, Drug; Female; Forecasting; Humans; Kidney; Male; Middle Aged; Models, Theoretical; Neoplasms; Organoplatinum Compounds; Regression Analysis | 2002 |
[Phase I study of a new platinum complex 254-S, cis-diammine (glycolato)-platinum (II)].
Topics: Adult; Aged; Antineoplastic Agents; Breast Neoplasms; Colonic Neoplasms; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infusions, Intravenous; Kidney; Lung Neoplasms; Male; Middle Aged; Neoplasms; Organoplatinum Compounds; Prostatic Neoplasms | 1992 |
[Preclinical and clinical evaluation of toxicity and antitumor activity of cisplatin analogues].
Topics: Animals; Antineoplastic Agents; Bone Marrow; Carboplatin; Cisplatin; Drug Evaluation; Drug Screening Assays, Antitumor; Humans; Kidney; Leukopenia; Mice; Neoplasms; Neoplasms, Experimental; Organoplatinum Compounds; Thrombocytopenia | 1989 |